Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mai F AlSakhen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|November 21, 2024
New 4-amino-3-chloro benzoate ester derivatives as EGFR inhibitors: synthesis, in silico and biological analysesNedaa A Abd Al Rahim, Ammar A Razzak Mahmood, Lubna H Tahtamouni, et al.
Chemistry & Biodiversity|December 25, 2023
New Indole-6-Carboxylic Acid Derivatives as Multi-Target Antiproliferative Agents: Synthesis, in Silico Studies, and Cytotoxicity EvaluationMustafa M Allawi, Ammar A Razzak Mahmood, Lubna H Tahtamouni, et al.
Current Medicinal Chemistry|May 2, 2024
Synthesis, <i>In Silico</i> Prediction, and <i>In Vitro</i> Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site InhibitorsWurood A Shihab, Ammar A Razzak Kubba, Lubna H Tahtamouni, et al.
Drug Development Research|July 3, 2024
Novel 1,3,4-oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluationHiba N Alsaad, Baan M Al-Jasani, Ammar A Razzak Mahmood, et al.
Future Medicinal Chemistry|August 7, 2024
Anti-proliferation evaluation of new derivatives of indole-6-carboxylate ester as receptor tyrosine kinase inhibitorsMustafa M Allawi, Ammar A Razzak Mahmood, Lubna H Tahtamouni, et al.
Drug Development Research|April 21, 2024
Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3-phenoxybenzoic acid as VEGFR-2 inhibitorsMohammad H Heriz, Ammar A R Mahmood, Salem R Yasin, et al.
Current Cancer Drug Targets|June 23, 2026
3D Bioprinted Senescent Caco2 Modeling Using a Low-Cost DIY 3D Bioprinter: Challenges and LimitationsSofian Al Shboul, Yazan Al Dweiri, Mai F AlSakhen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|November 21, 2024
New 4-amino-3-chloro benzoate ester derivatives as EGFR inhibitors: synthesis, in silico and biological analysesNedaa A Abd Al Rahim, Ammar A Razzak Mahmood, Lubna H Tahtamouni, et al.
Chemistry & Biodiversity|December 25, 2023
New Indole-6-Carboxylic Acid Derivatives as Multi-Target Antiproliferative Agents: Synthesis, in Silico Studies, and Cytotoxicity EvaluationMustafa M Allawi, Ammar A Razzak Mahmood, Lubna H Tahtamouni, et al.
Current Medicinal Chemistry|May 2, 2024
Synthesis, <i>In Silico</i> Prediction, and <i>In Vitro</i> Evaluation of Anti-tumor Activities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivatives as EGFR Allosteric Site InhibitorsWurood A Shihab, Ammar A Razzak Kubba, Lubna H Tahtamouni, et al.
Drug Development Research|July 3, 2024
Novel 1,3,4-oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluationHiba N Alsaad, Baan M Al-Jasani, Ammar A Razzak Mahmood, et al.
Future Medicinal Chemistry|August 7, 2024
Anti-proliferation evaluation of new derivatives of indole-6-carboxylate ester as receptor tyrosine kinase inhibitorsMustafa M Allawi, Ammar A Razzak Mahmood, Lubna H Tahtamouni, et al.
Drug Development Research|April 21, 2024
Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3-phenoxybenzoic acid as VEGFR-2 inhibitorsMohammad H Heriz, Ammar A R Mahmood, Salem R Yasin, et al.
Current Cancer Drug Targets|June 23, 2026
3D Bioprinted Senescent Caco2 Modeling Using a Low-Cost DIY 3D Bioprinter: Challenges and LimitationsSofian Al Shboul, Yazan Al Dweiri, Mai F AlSakhen, et al.
Pageof 1